ANI Pharmaceuticals, Inc.
ANIP
$61.43
-$2.34-3.67%
| 03/31/2024 | 12/31/2023 | 09/30/2023 | 06/30/2023 | 03/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 235.02% | 139.21% | 119.74% | 91.89% | 58.09% |
| Total Depreciation and Amortization | -0.03% | 0.23% | 4.16% | 12.19% | 17.45% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -77.25% | 86.20% | 1,241.17% | 838.01% | 403.39% |
| Change in Net Operating Assets | 138.89% | 148.46% | 22.17% | -11.07% | -128.30% |
| Cash from Operations | 1,163.82% | 481.24% | 279.08% | 185.96% | 125.25% |
| Capital Expenditure | -19.66% | 0.09% | -59.62% | -149.13% | -143.59% |
| Sale of Property, Plant, and Equipment | 1,701.87% | -- | -100.00% | -100.00% | -71.69% |
| Cash Acquisitions | -- | -- | 100.00% | 100.00% | 99.96% |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -31.07% | -27.23% | 5.80% | -4,516.21% | 65.43% |
| Cash from Investing | 54.60% | -17.62% | 82.20% | 74.13% | 85.12% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | 0.00% | 98.54% | 98.55% | 98.57% |
| Issuance of Common Stock | 5,606.27% | 6,042.04% | 14.11% | 8.21% | -97.91% |
| Repurchase of Common Stock | -130.05% | -154.57% | -164.80% | -165.31% | -164.46% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | 0.06% | 0.00% | -15.48% | -62.28% | -173.28% |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 805.85% | 1,415.63% | -54.90% | -57.05% | -103.80% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 1,236.36% | 422.44% | 221.22% | 138.53% | -127.30% |
